Carnitine administration reduces cytokine levels, improves food intake, and ameliorates body composition in tumor-bearing rats

Cancer Investigation

Volumn 29, Issue 10, 2011, Pages 696-700

  Laviano, Alessandro ^a   Molfino, Alessio ^a,b   Seelaender, Marilia ^c   Frascaria, Teresa ^a   Bertini, Giuseppe ^d   Ramaccini, Cesarina ^a   Bollea, Maria Rosa ^b   Citro, Gennaro ^d   Fanelli, Filippo Rossi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Istituti Fisioterapici Ospitalieri Rome   (Italy)

Author keywords

Anorexia; Cachexia; Cancer; Cytokines; Lean body mass; Propionylcarnitine

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; PROPIONYLCARNITINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY MASS; CACHEXIA; CONTROLLED STUDY; DRUG SCREENING; EXPERIMENTAL RAT; FAT MASS; FOOD INTAKE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SARCOMA; WEIGHT REDUCTION;

ANIMALS; ANOREXIA; BODY COMPOSITION; CACHEXIA; CARNITINE; CYTOKINES; EATING; MALE; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344;

EID: 81255207378     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2011.626476     Document Type: Article

References (27)

1. Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F. Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself. Nat Clin Pract Oncol 2005;2:158-165. (Pubitemid 40823167)
2. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, Macdonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489-485.
3. Muscaritoli M, Molfino A, Gioia G, Laviano A, Rossi Fanelli F. The "parallel pathway": a novel nutritional and metabolic approach to cancer patients. Intern Emerg Med 2011;6:105-112.
4. Laviano A, Inui A, Marks DL, Meguid MM, Pichard C, Rossi Fanelli F, Seelaender M. Neural control of the anorexia-cachexia syndrome. Am J Physiol Endocrinol Metab 2008;295:E1000-E1008.
5. Molfino A, Rossi-Fanelli F, Laviano A. The interaction between pro-inflammatory cytokines and the nervous system. Nat Rev Cancer 2009;99:224.
6. Wolfgang MJ, Kurama T, Dai Y, Suwa A, Asaumi M, Matsumoto S, Cha SH, Shimokawa T, Lane MD. The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc Natl Acad Sci USA 2006;103:7282-7287. (Pubitemid 43727824)
7. Cha SH, Hu Z, Chohnan S, Lane D. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proc Natl Acad Sci USA 2005;102:14557-14562. (Pubitemid 41457096)
8. Peluso G, Nicolai R, Reda E, Benatti P, Barbarisi A, Calvani M. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 2000;182:339-350. (Pubitemid 30054367)
9. Silverio R, Laviano A, Rossi Fanelli F, Seealander M. L-carnitine induces recovery of liver lipid metabolism in cancer cachexia. Amino Acids in press (Epub ahead of print; doi: 10.1007/s00726-011-0898-y).
10. Gramignano G, Lusso MR, Madeddu C, Massa, E, Serpe R, Deiana L, Lamonica G, Dessì M, Spiga C, Astara G, Macciò A, Mantovani G. Efficacy of L-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition 2006;22:136-145. (Pubitemid 43188803)
11. Vesci L, Tobia P, Corsico N, Martelli EA, Arduini A. Characterization and subcellular localization of L-[3H] carnitine binding sites in rat brain. J Neurochem 1995;64:2783-2791.
12. Broderick TL, Paulson DJ, Gillis M. Effects of propionyl-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart. Drugs RD 2004;5:191-201. (Pubitemid 39089505)
13. Suzuki H, Rounds JD, Wilmore DW. Does multifrequency bioelectrical impedance relate to body composition? J Surg Res 1996;65:63-69. (Pubitemid 26339196)
14. Meguid MM, Sato T, Torelli GF, Laviano A, Rossi Fanelli F. An analysis of temporal changes in meal number and meal size at onset of anorexia in male tumor-bearing rats. Nutrition 2000;16:305-306. (Pubitemid 30176060)
15. Haddad JJ. Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation. Biochem Biophys Res Commun 2002;296:847-856.
16. Karlic H, Lohninger A, Laschan C, Lapin A, Böhmer F, Huemer M, Guthann E, Rappold E, Pfeilstöcker M. Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. J Mol Med 2003;81:435-442. (Pubitemid 36900539)
17. Godarova A, Litzlbauer E, Brunner S, Agu AC, Lohninger A, Hofbauer R. L-carnitine regulates mRNA expression levels of the carnitine acyltransferases-CPT 1A, CPT 2 and CRAT. Chem Monthly 2005;136:1349-1363. (Pubitemid 41095365)
18. Savica V, Santoro D, Mazzaglia G, Ciolino F, Monardo P, Calvani M, Bellinghieri G, Kopple JD. L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients. J Ren Nutr 2005;15:225-230.
19. Kadiroglu AK, Yilmaz ME, Sit D, Kara ICH, Isikoglu B. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients. Ren Fail 2005;27:367-372. (Pubitemid 40993683)
20. Kazmi WH, Obrador GT, Sternberg M, Lindberg J, Schreiber B, LewisV, Pereira BJ. Carnitine therapy is associated with decreased hospital utilization among hemodialysis patients. Am J Nephrol 2005;25:106-115. (Pubitemid 40864179)
21. Shakeri A, Tabibi H, Hedayati M. Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia. Hemodial Int 2010;14:498-504.
22. Mantovani G, Madeddu C, Maccio A, Gramignano G, Lusso MR, Massa E, Astara G, Serpe R. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev 2004;13:1651-1659. (Pubitemid 39331888)
23. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-1142. (Pubitemid 36583097)
24. Laviano A, Meguid MM, Rossi Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 2003;4:686-694. (Pubitemid 37407436)
25. He W, Lam TKT, Obici S, Rossetti L. Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat Neurosci 2006;9:227-233. (Pubitemid 43164546)
26. Kazantzis M, Seelaender MC. Cancer cachexia modifies the zonal distribution of lipid metabolism-related proteins in rat liver. Cell Tissue Res 2005;321:419-427. (Pubitemid 41206995)
27. Heo YR, Kang CW, Cha YS. L-Carnitine changes the levels of insulin-like growth factors (IGFs) and IGF binding proteins in streptozotocin-induced diabetic rat. J Nutr Sci Vitaminol 2001;47:329-334.